Why the Fisher & Paykel Healthcare (ASX:FPH) share price could jump higher today

The Fisher & Paykel Healthcare Corp Ltd (ASX:FPH) share price could be pushing higher today after the release of a trading update…

| More on:
jump in asx share price represented by man jumping in the air in celebration

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Fisher & Paykel Healthcare Corp Ltd (ASX: FPH) share price could jump higher on Friday following the release of a trading update.

In New Zealand, the Fisher & Paykel Healthcare share price is currently up 6% in early trade.

How is Fisher & Paykel Healthcare performing?

Today's update reveals that Fisher & Paykel Healthcare has continued to experience strong demand for its products in FY 2021.

According to the release, operating revenue for the nine months ended 31 December 2020 was up 73% in constant currency compared to the prior corresponding period.

The main driver of this growth has been its Hospital Product segment. This includes products that are used in acute and chronic respiratory care and surgery.

Hospital Products operating revenue grew 113% over the first nine months of the previous financial year in constant currency.

Over this same period, management notes that Hospital hardware grew 446% and hospital consumables grew 54%, both in constant currency.

Growth in the company's Homecare Product segment has been a lot more subdued. This segment includes products used in the treatment of obstructive sleep apnoea (OSA) and respiratory support in the home. It competes head on with ResMed Inc (ASX: RMD) in this market.

The release explains that segment operating revenue grew 6% over the nine months to 31 December 2020 in constant currency.

Managing Director and Chief Executive Officer, Lewis Gradon, commented: "In many parts of the world, we have continued to see an influx of COVID-19 patients requiring hospitalisation for respiratory treatment."

"Given the elevated hospitalisation rates for COVID-19, our hospital hardware sales have continued to be very strong, as has the use of our hospital hardware," he added.

Outlook

When the company released its half year results, it provided investors with an idea of what it was expecting in FY 2021 based on a number of assumptions.

It guided to full year operating revenue of approximately NZ$1.72 billion and net profit after tax of approximately NZ$400 million to NZ$415 million.

This compares to FY 2020's operating revenue of NZ$1.26 billion and net profit after tax of NZ$287.3 million.

Pleasingly, the company notes that these assumptions are now outdated and the company currently expects revenue and net profit after tax to be higher than previous expectations.

However, due to significant uncertainties associated with the course of COVID-19, no formal guidance has been provided and investors will need to wait for its full year results to find out how it performs.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has recommended ResMed Inc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Gainers

Stock market chart in green with a rising arrow symbolising a rising share price.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a massive day for the ASX 200, with a new all-time high recorded.

Read more »

A man sits thoughtfully on the couch with a laptop on his lap.
Technology Shares

This ASX tech stock rocketed 60% in March! Can it keep on delivering?

After soaring in March, the ASX tech stock is now up 169% since this time last year.

Read more »

A young women pumps her fists in excitement after seeing some good news on her laptop.
Share Gainers

Why Mesoblast, Newmont, Pilbara Minerals, and Platinum shares are jumping

These ASX shares are ending the week strongly. But why?

Read more »

A young male ASX investor raises his clenched fists in excitement because of rising ASX share prices today
Share Gainers

3 ASX All Ords shares up 50%+ in March

These ASX shares have been on fire this month. But why?

Read more »

Woman looks amazed and shocked as she looks at her laptop.
Share Gainers

Why Mesoblast, Patriot Battery Metals, Sigma, and Zip shares are pushing higher

These shares are having a good session on hump day. But why?

Read more »

Woman looks amazed and shocked as she looks at her laptop.
Consumer Staples & Discretionary Shares

If you'd put $20,000 in this ASX retail stock at the start of 2023, you'd have $134,000 now

This online retailer has executed a remarkable turnaround for its investors.

Read more »

Fancy font saying top ten surrounded by gold leaf set against a dark background of glittering stars.
Share Gainers

Here are the top 10 ASX 200 shares today

It was back to earth for ASX shares this Tuesday.

Read more »

Two happy scientists analysing test results.
Healthcare Shares

Mesoblast share price rockets 36% on breaking FDA news

ASX investors are sending the Mesoblast share price soaring following promising FDA news.

Read more »